Chas Peyton retweeted
Your patient has had nephrectomy for high-risk clear cell RCC. The next decision: Surveillance, Pembrolizumab, or Pembrolizumab + belzutifan. Is adjuvant justified when surgery may already have been curative? Our new commentary explores this dilemma. 🧵bit.ly/4jkism6
Chas Peyton retweeted
We’re excited to welcome three new faculty members to the @UABHeersink Dept. of Urology!
Please join us in welcoming Daniel Roberson, M.D., Cameron Britton, M.D., and David Patrick Murray, M.D., who joined our department on Sept. 1 as assistant professors.
Chas Peyton retweeted
Recurrent bladder cancer is rarely as simple as treating the next tumor. Every recurrence raises a new decision: watch, treat in the office, or head back to the OR?
On this episode of the BackTable Urology Podcast, Dr. Charles Peyton (@ccp1983) joins Dr. Ruchika Talwar (@RuchikaTalwarMD) to discuss the evolving management of recurrent low-grade, intermediate-risk non-muscle-invasive bladder cancer. They cover everything from office-based management and repeat TURBTs to patient-reported outcomes, recurrence patterns, and the role of newer therapies like UGN-102. Throughout the discussion, one message remains clear: caring for recurrent NMIBC isn't just about treating the next tumor. It's about understanding the patient, the disease, and the decisions that shape long-term care.
🔗 Check out the full episode → backtable.com/shows/urology/…
#URO323 #BladderCancer #NMIBC #UrologicOncology #TURBT #BladderCancerAwareness @UABUrology @VUMChealth
Congratulations to these newly minted urologists from @UABUrology, great group doing big things @Zach_Burns @CorbinNorton @ANocera26! I’m humbled/honored to have been your @UABUrology teacher of their year, means a lot! You guys will be missed!
Great weekend. Canes win the cup again after 20 years…former team captain as our coach! Love it! Go @Canes!
And got to watch these boys play lax three weeks in a row.
Do you give intravascular heparin bolus prior to clamping for IVC thrombectomy? @UABUrology teamed up with @AydinAMurat and univ Arkansas examin outcomes. Great work team. Bottom line: case specific use at discretion of surgical team is all good!
sciencedirect.com/science/ar…
Chas Peyton retweeted
Heparin bolus with your IVC tumor thrombectomy? Great paper! sciencedirect.com/science/ar… @ccp1983 @UABUrology
Chas Peyton retweeted
Excited to see Dan Roberson presenting his poster at #AUA2026! We’re looking forward to welcoming him to @UABHeersink Dept. of Urology this summer.
@SES_AUA @DSRoberson93
Chas Peyton retweeted
We’re excited to see @UABHeersink Urology research on display at #AUA2026! Ethan Wan, MS3, presenting “Long-term Renal Function After Radical Nephrectomy and IVC Thrombectomy: A Multicenter Analysis.”
@ccp1983 | @KartikPatel___ | @afang5604 | @AydinAMurat | @AmerUrological

ALT Group photo of three conference attendees standing in front of a research poster titled “Long‑term Renal Function After Radical Nephrectomy and IVC Thrombectomy: A Multicenter Analysis.” The poster displays study background, methods, results, and data visualizations, with UAB Medicine branding visible.

ALT Presenter standing beside a research poster at a conference poster session, holding a microphone and gesturing while speaking. The poster is titled “Long‑term Renal Function After Radical Nephrectomy and IVC Thrombectomy: A Multicenter Analysis” and includes charts, graphs, and institutional logos from UAB Medicine and UAMS Health.
Chas Peyton retweeted
Less Is More? How Much Bacillus Calmette-Guérin (BCG) Is Enough for BC... sciencedirect.com/science/ar…
Chas Peyton retweeted
Ethan Wan, MS2, with residents and faculty in the @UABHeersink Department of Urology, explore the utility of blue light cytoscopy across the disease spectrum of bladder cancer.
Read more: buff.ly/zf4wV1A
@UABHeersink
Chas Peyton retweeted
Andrew Fang, M.D., joined the @UABHeersink Department of Urology as an assistant professor in September 2025. Get to know him more in this new faculty feature! ⭐ buff.ly/X5F05zW
Chas Peyton retweeted
Four @UABHeersink medical students who completed a rotation with UAB Urology this year have officially matched into residency programs! ⭐ We are so proud of you! @brejjettealjabi @KartikPatel___ @BrodyRhodes @donovanwtsn @UTSWMedCenter @OhioState @TempleUniv #UrologyMatch2026
Great lineup! Looking forward to our inaugural Dr. Dean Assimos VP event!!
COMING UP: Jan. 9, we will welcome 3 nationally renowned urology leaders: Dr. Kathleen Kobashi, Dr. Ojas Shah, & Dr. Ganesh Palapattu. Join us for engaging discussions and expert insights!
@uabheersink
@shah_ojas
@KKseattle
@gpalapa2
@ColumbiaUrology
@MethodistHosp
@UMichUrology
Chas Peyton retweeted
This evening was our @UABUrology “not a holiday” gathering. In this season, I am so grateful for this opportunity and am astounded at the energy, enthusiasm and empathy of my peers and our trainees. It’s truly amazing to be part of this team. Check us out. We are growing!
Chas Peyton retweeted
🚨TOMORROW🚨
Virtual Open House introducing the Genitourinary Reconstruction and Prosthetics Fellowship at @UABUrology!
📅 Date: November 18
🕕 Time: 6:00 PM CST
🔗 Register here for the Zoom link: uab.zoom.us/meeting/regist…
We look forward to meeting future applicants and sharing what makes our program unique!
@SocietyGURS @SMSNA
Great meeting at #SIU2025Edinburgh! Last dinner with Mark Preston, Scott Gilbert, Seth Learner, @AFeldmanMD, @Agarwal_CaB and @samsimsal. Excellent sharing war stories and experiences with this bunch! Thank you @SIU_urology for the invitation!
Chas Peyton retweeted
Great talks at NMIBC session at #SIU2025Edinburgh! Lucky to be in a session with @ccp1983, @niyatilobo, @pcvblack, @AFeldmanMD! Thanks to @SWilliams_MD for presenting and moderating!



























